Yes, it was a good month! With the rise due to the announced Pfizer collaboration I wrote about a week or two ago. No data to back it up, as Pfizer won’t even start promoting Cologard until Q4, but I think it is going to prove to be HUGE for EXAS growth.
https://marketrealist.com/2018/09/exact-sciences-posted-52-2…